CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Active TNSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03888391
NCT03888391N/ACompleted
CompareCT.gov

12 Month Open Extension Study of TNS for ADHD .

James McGough·interventional·Posted Mar 25, 2019·Updated May 29, 2019

In Brief

A clinical study evaluating Active TNS for Attention Deficit Hyperactivity Disorder (ADHD). Completed, enrolled 18 participants across 1 site.

Detailed Summary

Participants who exhibit sufficient ADHD symptom improvement in a prior study of active TNS will be invited to continue in a 12-month extension study, designed to collect additional data on long-term response and tolerability and to provide participants ongoing clinical benefit from treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAttention Deficit Hyperactivity Disorder (ADHD)
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 25, 2019
Enrollment StartDec 1, 2014
Primary CompletionMay 30, 2018
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 7.3 years ago

Interventions

Active TNSdevice